Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4918 total record number 290 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 70 out of 492
4918 citations found

Teriflunomide Promotes Blood-Brain Barrier Integrity by Upregulating Claudin-1 via the Wnt/β-catenin Signaling Pathway in Multiple Sclerosis

Yipeng, Z;Chen, C;Xiuqing, X;Ling, F;Yanyu, C;Xi, C;Fuhua, P;Jingqi, W;Shishi, S;Shilin, W;Wei, C;Wei, Q;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • Induction of EAE model

    Female Lewis rats at 6-8 weeks of age were purchased from Beijing Vital River Laboratory Animal
    Technology Co., Ltd (Beijing, China). The antigen emulsion was prepared from an emulsion of guinea pig
    spinal cord white matter homogenates in phosphate-buffered saline (PBS, 50% w/v) mixed with an equal
    volume of complete Freund’s adjuvant (Sigma-Aldrich) supplemented with 4 mg/mL Mycobacterium
    tuberculosis. Each rat was immunized by subcutaneous injection of antigen emulsion at a dose of 0.75
    ml/kg into its footpad, followed by an auxiliary injection of 8 μg/kg diluted in 0.5 mL pertussis toxin (List
    Biological Laboratories)
    in the dorsum of the foot. The second immunization was administered 7 days
    after the first immunization. …

    Author did not specify which List Labs Pertussis Toxin was utilized. List Labs provides the following Pertussis Toxin products:
    Product #180 – Pertussis Toxin from B. pertussis, Lyophilized in Buffer
    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)
    Product #179A – Pertussis Toxin from B. pertussis (in Glycerol)

Product: Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

Discovery of new macrophage M2 polarization modulators as multiple sclerosis treatment agents that enable the inflammation microenvironment remodeling

Che, J;Li, D;Hong, W;Wang, L;Guo, Y;Wu, M;Lu, J;Tong, L;Weng, Q;Wang, J;Dong, X;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

NAD+ metabolism drives astrocyte proinflammatory reprogramming in central nervous system autoimmunity

Meyer, T;Shimon, D;Youssef, S;Yankovitz, G;Tessler, A;Chernobylsky, T;Gaoni-Yogev, A;Perelroizen, R;Budick-Harmelin, N;Steinman, L;Mayo, L;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Blockade of the Adenylate Cyclase Toxin Synergizes with Opsonizing Antibodies to Protect Mice against Bordetella pertussis

DiVenere, AM;Amengor, D;Silva, RP;Goldsmith, JA;McLellan, JS;Maynard, JA;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

The HSP90 inhibitor 17-DMAG alleviates primary biliary cholangitis via cholangiocyte necroptosis prevention

Chen, L;Fan, H;Chu, H;Du, F;Chen, Y;Hu, L;Li, Z;Wang, W;Hou, X;Yang, L;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Lipopolysaccharide affects energy metabolism and elevates nicotinamide N-methyltransferase level in human aortic endothelial cells (HAEC)

St?pi?ska, O;Dymkowska, D;Mateuszuk, ?;Zab?ocki, K;

Product: ULTRA PURE LPS from Escherichia coli O111:B4

  • 2.1. Cell culture and treatment

    HAECs were purchased from Lonza. Cells were grown in EGM BulletKit®−2 (Lonza) at 37ºC in an atmosphere of 5% CO2 and 95% air. The culture medium was composed exactly as recommended by the supplier (Lonza). Confluent cells were exposed to 100 ng/ml LPS (Escherichia coli O111:B4, List Biological Laboratories, #421) for a period within 0.5 h to 24 h as indicated in figure legends. In all experiments, cells of the third passage were used.

    Product #421 – ULTRA PURE LPS from Escherichia coli O111:B4

AMPK-Nrf2 Signaling Pathway in Phrenic Motoneurons following Cervical Spinal Cord Injury

Michel-Flutot, P;Efthimiadi, L;Djerbal, L;Deramaudt, T;Bonay, M;Vinit, S;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

  • 2.2. Animal Groups and Surgical Preparation

    In this study, 63 animals were used, divided into 9 groups: control (n = 4), Sham animals (at 1 h (n = 6), 1 day (n = 7), 3 days (n = 7), and 7 days (n = 7) post-surgery), and C2-injured animals (at 1 h (n = 8), 1 day (n = 8), 3 days (n = 8), and 7 days (n = 8) post-injury). None of the C2-injured animals died during or after the procedure, however one Sham animal died at 1 h due to a technical issue. All animals (except n = 4 of each group) received an intrapleural injection with the retrograde tracer Cholera toxin B fragment (CTB, List Biologicals, Campbell, CA, USA) to identify phrenic motor neurons in the cervical spinal cord, similar to that described previously [41,42,43,44]. Briefly, each rat was anaesthetized with isoflurane (Iso-vet, Piramal, Voorschoten, Netherlands; ~1.5% in O2), placed in the supine position on a surgical table while spontaneously breathing into a face mask. The lateral sides of the rib cage were shaved and gently palpated to identify the fifth intercostal space at the anterior axillary line. A sterilized 26G needle connected to a 50 μL Hamilton syringe was used to inject 25 μL of a 0.2% CTB (dissolved in sterile injectable saline) between the 5th and the 6th ribs into the pleural space on each side. …

    Product #104 – Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

IκBζ controls IL-17-triggered gene expression program in intestinal epithelial cells that restricts colonization of SFB and prevents Th17-associated pathologies

Yamazaki, S;Inohara, N;Ohmuraya, M;Tsuneoka, Y;Yagita, H;Katagiri, T;Nishina, T;Mikami, T;Funato, H;Araki, K;Nakano, H;

Product: LPS from Escherichia coli O111:B4

The expression of nerve growth factor in healthy and inflamed equine chondrocytes analysed by capillary western immunoassay

Nyström, S;Kendall, A;Adepu, S;Lindahl, A;Skiöldebrand, E;

Product: LPS from Escherichia coli O55:B5

  • 2.1. Chondrocyte isolation and culture

    … Samples were placed in sterile saline (0.9% NaCl) solution with gentamicin sulfate (50 mg/l) and amphotericin B (250 μg/ml). The cartilage samples were transported chilled (approx. 5 °C) to the laboratory. Isolation and expansion of chondrocytes were performed as previously described (Ley et al., 2011). Briefly, the chondrocytes were expanded to passage 1 and then seeded at 20,000 cells/cm2 in chondrogenic medium to maintain the phenotype. On day 4, cells were stimulated with LPS (10 ng/ml, Escherichia coli 055:B5; List Biological Laboratories, Campbell, CA, USA) or kept untreated (controls) for 24 h. Cells were grown to confluence and harvested on day 5 and immediately frozen and stored at −80 °C until further analyses.

    Product #203A – LPS from Escherichia coli O55:B5